Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy
The combined inhibition of histone deacetylases (HDAC) and the proteins of the bromodomain and extraterminal (BET) family have recently shown therapeutic efficacy against melanoma, pancreatic ductal adenocarcinoma, testicular, and lymphoma cancers in murine studies. However, in such studies, the rol...
Main Authors: | Badamchi-Zadeh, Alexander, Moynihan, Kelly Dare, Larocca, Rafael A., Aid, Malika, Provine, Nicholas M., Iampietro, M. Justin, Kinnear, Ekaterina, Penaloza-MacMaster, Pablo, Abbink, Peter, Blass, Eryn, Tregoning, John S., Irvine, Darrell J, Barouch, Dan H. |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
American Association of Immunologists
2020
|
Online Access: | https://hdl.handle.net/1721.1/126247 |
Similar Items
-
Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy
by: Badamchi-Zadeh, A, et al.
Published: (2018) -
Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4(+) T cell responses that impair CD8(+) T cell function
by: Larocca, R, et al.
Published: (2016) -
Immediate dysfunction of vaccine-elicited CD8+ T cells primed in the absence of CD4+ T cells
by: Provine, N, et al.
Published: (2016) -
Immunogenicity and cross-reactivity of rhesus adenoviral vectors
by: Iampietro, M, et al.
Published: (2018) -
Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo.
by: Lawrence J Tartaglia, et al.
Published: (2019-12-01)